Browse the corpus

Liver biopsy remains the gold standard for diagnosing various liver disorders. With advancements in techniques, this procedure has become a safe and valuable tool for hepatologists managing a wide range of liver pathologies. A liver biopsy is indicated for diagnosing various hepatic conditions as well as serving as a prognostic tool, particularly in diseases like nonalcoholic steatohepatitis (NASH) and hemochromatosis, where the presence of fibrosis or cirrhosis carries significant prognostic implications. Several liver biopsy methods, including percutaneous, transvenous, laparoscopic, and plugged biopsy techniques, can be utilized. Each method has specific indications based on patient factors (eg, the risk of bleeding or the need for a targeted biopsy). Despite the availability of noninvasive markers, liver biopsy remains an essential diagnostic tool due to its ability to provide detailed histological evaluation, which is crucial for accurate diagnosis and effective management. This activity for healthcare professionals is designed to enhance the learner's competence in performing liver biopsies, identifying indications, and implementing an appropriate interprofessional management approach to improve patient outcomes. Objectives: Implement appropriate techniques for a liver biopsy. Evaluate the indications for a liver biopsy. Assess the complications of a liver biopsy. Apply interprofessional team strategies to improve care coordination and outcomes for patients undergoing a liver biopsy. Access free multiple choice questions on this topic.

Liver biopsy remains the gold standard for diagnosing various liver disorders. Though the first needle biopsy of the liver was reported to have been performed by Paul Ehrlich in 1883, with advancements in techniques, this procedure has become a safe and valuable tool for hepatologists managing a wide range of liver pathologies.[1][2][3] A liver biopsy is indicated for diagnosing conditions such as chronic hepatitis, cirrhosis, storage diseases, unexplained hepatomegaly, and drug-induced liver injury. It also serves as a prognostic tool, particularly in diseases like nonalcoholic steatohepatitis (NASH) and hemochromatosis, where the presence of fibrosis or cirrhosis carries significant prognostic implications. Furthermore, liver biopsy is crucial in guiding treatment, especially in autoimmune hepatitis, where it helps monitor disease activity and treatment compliance. Several liver biopsy methods, including percutaneous, transvenous, laparoscopic, and plugged biopsy techniques, can be utilized. Each method has specific indications based on patient factors (eg, the risk of bleeding or the need for a targeted biopsy). Despite the availability of noninvasive markers, liver biopsy remains an essential diagnostic tool due to its ability to provide detailed histological evaluation, which is crucial for accurate diagnosis and effective management.

Liver biopsy is a very safe procedure in the hands of skilled operators. The overall rate of serious complications was approximately 1% in 2 large series, while in another, the overall mortality risk was estimated to be 0.2%. The usual indicators of complications requiring overnight hospital observation are severe abdominal or shoulder tip pain not relieved with 1 dose of parenteral analgesic, hypotension, or tachycardia following the procedure.[8] Pain Pain is the most common complication after liver biopsy. It can be seen in up to 84% of patients, most commonly at the biopsy site, the right shoulder (often indicating a subcapsular hematoma), or both. In most patients, pain is usually controlled with analgesics. However, severe persistent pain should alert the physician to investigate serious causes of pain, like bile peritonitis or hemorrhage. The patient may require admission and radiological assessment. Bleeding Complications The risk of fatal hemorrhage in patients without malignant disease is 0.04%, and the risk of nonfatal hemorrhage is 0.16%. In those with malignancy, the risk of nonfatal hemorrhage is 0.4%, and 0.57% for nonfatal hemorrhage. Bleeding complications typically fall into 3 main types: free intraperitoneal bleeding, intrahepatic and subcapsular hematomas, and hemobilia. Free intraperitoneal bleed Free intraperitoneal bleeding can be secondary to liver laceration with deep breathing during the intercostal procedure, perforation of distended portal or hepatic veins or aberrant arteries, or inadvertent puncture of a major intrahepatic blood vessel. The patients usually present with hemodynamic instability, severe abdominal pain, and a rapid drop in hemoglobin. Early recognition of this complication is imperative. The patient should be admitted and resuscitated, and both interventional radiology and a surgeon should be consulted. Angiographic embolization is usually successful in controlling the bleeding, but in rare cases, surgical intervention might be required, particularly in the transplant patient who carries a higher risk for significant bile duct injury with arterial embolization. Rarely, bleeding can be intrathoracic from an intercostal artery. Intrahepatic and subcapsular hematoma

Free intraperitoneal bleeding can be secondary to liver laceration with deep breathing during the intercostal procedure, perforation of distended portal or hepatic veins or aberrant arteries, or inadvertent puncture of a major intrahepatic blood vessel. The patients usually present with hemodynamic instability, severe abdominal pain, and a rapid drop in hemoglobin. Early recognition of this complication is imperative. The patient should be admitted and resuscitated, and both interventional radiology and a surgeon should be consulted. Angiographic embolization is usually successful in controlling the bleeding, but in rare cases, surgical intervention might be required, particularly in the transplant patient who carries a higher risk for significant bile duct injury with arterial embolization. Rarely, bleeding can be intrathoracic from an intercostal artery. Intrahepatic and subcapsular hematoma Intrahepatic and subcapsular hematoma can be seen even in asymptomatic patients. Bleeding usually presents with pain, tachycardia, and a mild drop in hemoglobin with a rise in serum transaminases. If large, they can cause right upper quadrant tenderness and hepatomegaly and appear as triangular hyper-dense segments in the arterial phase of the CT scan. Most patients can be managed with conservative treatment, and radiological or surgical intervention is rarely required. Hemobilia Hemobilia usually presents with the classical triad of gastrointestinal bleeding, biliary pain, and jaundice. The bleeding is typically arterial in origin but can be venous in patients with preexisting portal hypertension. Hemobilia can vary in severity from the occult to exsanguinating hemorrhage. This bleeding complication rarely presents acutely and most commonly presents after a median of 5 days with the gradual erosion of a biopsy-induced hematoma or pseudoaneurysm into the bile duct. The presentation can vary from hemodynamically significant bleeding to chronic anemia. Imaging or endoscopy can make a diagnosis. Treatment depends on the severity of the bleed. Hemodynamically significant radiologic intervention may be required. ERCP might be needed in some cases to remove clotted blood from the bile duct, causing obstruction and cholangitis. Transient Bacteremia

Hemobilia usually presents with the classical triad of gastrointestinal bleeding, biliary pain, and jaundice. The bleeding is typically arterial in origin but can be venous in patients with preexisting portal hypertension. Hemobilia can vary in severity from the occult to exsanguinating hemorrhage. This bleeding complication rarely presents acutely and most commonly presents after a median of 5 days with the gradual erosion of a biopsy-induced hematoma or pseudoaneurysm into the bile duct. The presentation can vary from hemodynamically significant bleeding to chronic anemia. Imaging or endoscopy can make a diagnosis. Treatment depends on the severity of the bleed. Hemodynamically significant radiologic intervention may be required. ERCP might be needed in some cases to remove clotted blood from the bile duct, causing obstruction and cholangitis. Transient Bacteremia Transient bacteremia is usually clinically insignificant except in patients with obstructive jaundice, like primary sclerosing cholangitis, or in the post-transplant setting. Currently, no prophylactic antibiotic treatment recommendations have been established, and treatment can be offered on a case-by-case basis. Bile Peritonitis Bile peritonitis can occur with the inadvertent puncture of the gallbladder or in patients with obstructive jaundice and dilated bile ducts. It usually presents with abdominal pain, fever, and leukocytosis, but bile peritonitis can also be painless in some patients. Biliary scintigraphy demonstrates the leak. Treatment generally includes fluids and antibiotics. Very rarely, endoscopic procedures like ERCP or surgery may be required. Miscellaneous Complications Cardiovascular complications, especially in patients with preexisting heart disease, arteriovenous fistula, and pneumothorax, are other rare reported complications. Carcinoid crisis can occur after the percutaneous biopsy.

Effective liver biopsy care requires a coordinated, interprofessional approach involving physicians, advanced practitioners, nurses, pharmacists, and other health professionals. The procedure, typically performed by a radiologist, gastroenterologist, or general surgeon, must be followed by vigilant post-procedure monitoring by nurses. This includes assessing vital signs, abdominal distension, and pain levels to detect complications such as bleeding, which can occur up to 24 hours post-biopsy. Pharmacists are crucial in managing medications that may affect coagulation, while advanced practitioners and physicians must ensure proper patient preparation and follow-up care. Strong interprofessional communication and collaboration are essential to enhance patient-centered care, safety, outcomes, and overall team performance during liver biopsy management.